Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.

Keime-Guibert, F; Graus, F; Broët, P; Reñé, R; Molinuevo, J L; Ascaso, C; Delattre, J Y

Keime-Guibert, F; Graus, F; Broët, P; Reñé, R; Molinuevo, J L; Ascaso, C; Delattre, J Y.

Affiliation

Keime-Guibert F; Services of Neurology, Hôpital de la Salpêtrière, Paris, France.

Neurology ; 53(8): 1719-23, 1999 Nov 10.

Article in En | MEDLINE | ID: mdl-10563618

Subject(s)

Antibodies/analysis; Encephalomyelitis/immunology; Encephalomyelitis/therapy; Immunotherapy; Nerve Tissue Proteins; Paraneoplastic Syndromes/immunology; Paraneoplastic Syndromes/therapy; RNA-Binding Proteins/immunology; Adult; Aged; Carcinoma, Small Cell/complications; Carcinoma, Small Cell/therapy; Disease Progression; ELAV Proteins; Encephalomyelitis/complications; Female; Humans; Lung Neoplasms/complications; Lung Neoplasms/therapy; Male; Middle Aged; Paraneoplastic Syndromes/complications; Retrospective Studies; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paraneoplastic Syndromes / RNA-Binding Proteins / Encephalomyelitis / Immunotherapy / Antibodies / Nerve Tissue Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 1999 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links